Joji Nakamura

Adenosine A_2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

Tomoyuki Kanda, Michael Jackson, Lance A. Smith et al. · Annals of Neurology · 1998 · 356 citations

Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

Tomoyuki Kanda, Michael S. Jackson, Lance A. Smith et al. · Experimental Neurology · 2000 · 246 citations

Neurophysiology, Medicine, Selective D1 +11

Actions of adenosine A 2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

Shizuo Shiozaki, Shunji Ichikawa, Joji Nakamura et al. · Psychopharmacology · 1999 · 215 citations

Neurophysiology, Medicine, Drug-induced Catalepsy +9

Studies on cardiotonic agents. II. Synthesis of novel phthalazine and 1,2,3-benzotriazine derivatives.

Yuji Nomoto, H. OBASE, H. TAKAI et al. · Chemical and Pharmaceutical Bulletin · 1990 · 155 citations · Full text

Anesthetized Dogs, Organic Chemistry, Pharmacotherapy +17

KF17837: A novel selective adenosine A2A receptor antagonist with anticataleptic activity

Tomoyuki Kanda, Shizuo Shiozaki, Junichi Shimada et al. · European Journal of Pharmacology · 1994 · 146 citations

Molecular Pharmacology, Functional Selectivity, Medicine +8